Home/OBI Pharma/Heidi Wang
HW

Heidi Wang

CEO

OBI Pharma

Therapeutic Areas

OBI Pharma Pipeline

DrugIndicationPhase
OBI-902Solid Tumors (TROP2‑expressing)Phase 1/2